Talis Biomedical (TLIS) Short Interest Ratio & Short Volume $1.25 0.00 (0.00%) As of 07/17/2025 Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Talis Biomedical Short Interest DataTalis Biomedical (TLIS) has a short interest of 5,400 shares, representing 0.55% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 3.4, indicating that it would take 3.4 days of the average trading volume of 2,552 shares to cover all short positions.Current Short Interest5,400 sharesPrevious Short Interest5,400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$7.56 thousandShort Interest Ratio3.4 Days to CoverLast Record DateJune 30, 2025Outstanding Shares1,823,000 sharesShort Percent of Float0.55%Today's Trading Volume36 sharesAverage Trading Volume2,552 sharesToday's Volume Vs. Average1% Short Selling Talis Biomedical? Sign up to receive the latest short interest report for Talis Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTLIS Short Interest Over TimeTLIS Days to Cover Over TimeTLIS Percentage of Float Shorted Over Time Talis Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20255,400 shares $7.56 thousand No Change0.5%3.4 $1.40 6/15/20255,400 shares $7.61 thousand No Change0.5%6 $1.41 5/31/20255,400 shares $8.10 thousand No Change0.5%10.8 $1.50 5/15/20255,400 shares $7.61 thousand No ChangeN/A18 $1.41 4/30/20255,400 shares $8.64 thousand No ChangeN/A54 $1.60 4/15/20255,400 shares $9.18 thousand No ChangeN/A2 $1.70 3/14/20255,400 shares $8.64 thousand No ChangeN/A0.8 $1.60 2/14/20255,600 shares $10.64 thousand No ChangeN/A14 $1.90 1/31/20255,600 shares $8.79 thousand -41.1%N/A1.4 $1.57 8/31/202420,100 shares $88.04 thousand +11.7%1.2%0.7 $4.38 Get the Latest News and Ratings for TLIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Talis Biomedical and its competitors with MarketBeat's FREE daily newsletter. 8/15/202418,000 shares $74.52 thousand -15.5%1.1%1 $4.14 7/31/202421,300 shares $184.78 thousand +52.1%1.3%1.5 $8.68 7/15/202414,000 shares $118.16 thousand -4.8%0.8%2.1 $8.44 6/30/202414,700 shares $127.33 thousand +9.7%0.9%2 $8.66 6/15/202413,400 shares $119.39 thousand No Change0.8%1.8 $8.91 5/31/202413,400 shares $123.28 thousand +5.5%0.8%1.8 $9.20 5/15/202412,700 shares $113.67 thousand -5.2%0.8%1.6 $8.95 4/30/202413,400 shares $115.51 thousand +8.9%0.8%1.5 $8.62 4/15/202412,300 shares $104.43 thousand -7.5%0.7%1.4 $8.49 3/31/202413,300 shares $116.38 thousand -4.3%0.8%1.5 $8.75 3/15/202413,900 shares $126.49 thousand +6.9%0.8%1.5 $9.10 2/29/202413,000 shares $104.52 thousand -8.5%0.8%1.3 $8.04 2/15/202414,200 shares $121.27 thousand -22.4%0.9%1.3 $8.54 1/31/202418,300 shares $142.01 thousand +7.0%1.1%1.1 $7.76 1/15/202417,100 shares $139.37 thousand +18.8%1.0%1 $8.15 12/31/202314,400 shares $107.28 thousand -37.7%0.9%0.9 $7.45 12/15/202323,100 shares $185.96 thousand +1.8%1.4%1.4 $8.05 11/30/202322,700 shares $173.66 thousand +33.5%1.4%1.5 $7.65 11/15/202317,000 shares $125.12 thousand -0.6%1.0%1.2 $7.36 10/31/202317,100 shares $81.74 thousand +19.6%1.0%2.5 $4.78 10/15/202314,300 shares $75.79 thousand +24.4%0.9%2.2 $5.30 9/30/202311,500 shares $66.36 thousand -25.8%0.7%1.1 $5.77 9/15/202315,500 shares $95.95 thousand +10.7%0.9%1.2 $6.19 8/31/202314,000 shares $86.80 thousand -21.8%0.8%1.1 $6.20 8/15/202317,900 shares $127.45 thousand -20.8%1.1%1.2 $7.12 7/31/202322,600 shares $169.05 thousand -5.8%1.4%1.5 $7.48 7/15/202324,000 shares $189.28 thousand +56.9%1.5%1.7 $7.89 6/30/202315,300 shares $110.16 thousand -94.1%0.9%1.3 $7.20 6/15/2023258,600 shares $116.63 thousand +42.4%1.1%2.1 $0.45 5/31/2023181,600 shares $89.06 thousand -27.0%0.8%1.6 $0.49Altucher: Turn $900 into $108,000 in just 12 months? (Ad)Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this marks the beginning of “Trump’s Great Gain,” a new crypto bull phase driven by emerging federal policies. He believes certain altcoins could turn $900 into $108,000 — and reveals everything in a new presentation.See Altucher’s Great Gain gameplan here 5/15/2023248,600 shares $111.87 thousand -25.2%1.0%2.9 $0.45 4/30/2023332,400 shares $162.88 thousand +21.4%1.4%3.9 $0.49 4/15/2023273,900 shares $127.12 thousand -7.6%1.1%3 $0.46 3/31/2023296,300 shares $145.19 thousand +6.0%1.2%3.4 $0.49 3/15/2023279,500 shares $156.80 thousand +10.7%1.2%2.4 $0.56 2/28/2023252,400 shares $146.39 thousand -10.6%1.1%2.2 $0.58 2/15/2023282,200 shares $172.51 thousand +25.3%1.2%2.5 $0.61 1/31/2023225,300 shares $141.51 thousand -4.1%0.9%2.1 $0.63 1/15/2023234,800 shares $135.36 thousand -9.7%1.0%2.1 $0.58 12/30/2022260,000 shares $115.88 thousand +10.5%1.1%2.1 $0.45 12/15/2022235,300 shares $128.71 thousand +3.4%1.0%2.2 $0.55 11/30/2022227,600 shares $124.88 thousand -1.0%1.0%2 $0.55 11/15/2022230,000 shares $115.05 thousand -28.3%1.0%1.8 $0.50 10/31/2022320,900 shares $213.43 thousand +13.0%1.3%1.5 $0.67 10/15/2022283,900 shares $196.12 thousand +1.1%1.2%1.3 $0.69 9/30/2022280,800 shares $191.39 thousand +14.3%1.2%1.4 $0.68 9/15/2022245,600 shares $219.22 thousand -0.4%1.0%1.1 $0.89 8/31/2022246,500 shares $221.85 thousand -19.3%1.0%1.1 $0.90 8/15/2022305,400 shares $264.26 thousand +14.9%1.3%1.3 $0.87 7/31/2022265,900 shares $210.06 thousand -10.2%1.1%1.6 $0.79 7/15/2022296,200 shares $258.88 thousand -13.8%1.2%1.7 $0.87 6/30/2022343,700 shares $279.08 thousand -57.3%1.4%1.9 $0.81 6/15/2022804,300 shares $770.44 thousand +0.7%3.3%4.4 $0.96 5/31/2022798,500 shares $838.43 thousand +11.9%3.3%4.3 $1.05 5/15/2022713,300 shares $699.03 thousand +1.2%3.0%4.2 $0.98 4/30/2022705,100 shares $740.36 thousand +27.5%2.9%4.7 $1.05 4/15/2022553,000 shares $707.84 thousand +0.6%2.3%4 $1.28 3/31/2022549,700 shares $775.08 thousand +9.0%2.3%4 $1.41 3/15/2022504,300 shares $852.27 thousand -0.9%2.1%3.4 $1.69 2/28/2022508,900 shares $1.06 million +8.8%2.1%3.8 $2.09 2/15/2022467,900 shares $1.02 million -10.6%2.0%3 $2.18 1/31/2022523,300 shares $1.54 million -4.3%2.3%2.7 $2.95 1/15/2022546,900 shares $1.78 million -28.5%2.5%2.9 $3.26 12/31/2021764,700 shares $3.07 million -16.9%3.4%3.9 $4.01 12/15/2021919,700 shares $3.72 million +33.1%4.1%4.7 $4.04 11/30/2021691,200 shares $3.23 million -63.8%3.1%3.5 $4.68 11/15/20211,910,000 shares $11.08 million +11.1%8.6%9.9 $5.80 10/29/20211,720,000 shares $9.20 million +11.7%7.9%7.8 $5.35 10/15/20211,540,000 shares $8.81 million +10.8%7.1%6.6 $5.72 9/30/20211,390,000 shares $8.69 million +8.6%6.4%4.2 $6.25 9/15/20211,280,000 shares $9.60 million -4.5%5.9%3.7 $7.50 8/31/20211,340,000 shares $10.80 million -19.3%6.2%3.6 $8.06 8/13/20211,660,000 shares $12.85 million No Change7.6%4.6 $7.74 TLIS Short Interest - Frequently Asked Questions What is Talis Biomedical's current short interest? Short interest is the volume of Talis Biomedical shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 5,400 shares of TLIS short. 0.55% of Talis Biomedical's shares are currently sold short. Learn More on Talis Biomedical's current short interest. What is a good short interest ratio for Talis Biomedical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TLIS shares currently have a short interest ratio of 3.0. Learn More on Talis Biomedical's short interest ratio. What is a good short interest percentage for Talis Biomedical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.55% of Talis Biomedical's floating shares are currently sold short. How does Talis Biomedical's short interest compare to its competitors? 0.55% of Talis Biomedical's shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Talis Biomedical: Schmitt Industries, Inc. (0.00%), Telesis Bio, Inc. (0.02%), ThermoGenesis Holdings, Inc. (0.02%), HTG Molecular Diagnostics, Inc. (0.07%), Trane Technologies plc (1.49%), Keysight Technologies Inc. (1.66%), Veralto Corporation (0.00%), Fortive Corporation (1.77%), Teradyne, Inc. (4.33%), Revvity Inc. (5.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Talis Biomedical stock? Short selling TLIS is an investing strategy that aims to generate trading profit from Talis Biomedical as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Talis Biomedical? A short squeeze for Talis Biomedical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TLIS, which in turn drives the price of the stock up even further. How often is Talis Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLIS, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies SMIT Short Interest Data TBIO Short Interest Data THMO Short Interest Data HTGMQ Short Interest Data PRENW Short Interest Data QSIAW Short Interest Data TT Short Interest Data KEYS Short Interest Data VLTO Short Interest Data FTV Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TLIS) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredSteve Jobs' Deathbed Secret Finally LeakedLeaked: Jobs’ Final Apple Project Exposed Bloomberg just leaked details of a secret project Steve Jobs set ...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talis Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talis Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLIS Stock Alerts